Last updated 2026-08-23
- Raised $1.5M Pre-Seed round led by Mayo Clinic, Mar 2026
Total raised
$1.5M
Last: Undisclosed Round 2026-03
Stage
Seed
Founded
2025
Headcount
8
HQ
Tel Aviv, Israel
Sector
Medical Devices
About
Sub-Q Bionics is a medical technology company developing an implantable lymphatic drainage system intended to manage lymphedema, a chronic condition often experienced by cancer survivors. The company's technology is designed to assist lymphatic circulation through an implantable device that works beneath the skin to help move lymphatic fluid and address the swelling, discomfort, and mobility limitations associated with the disease. Their novel bionic lymph node technology is based on scientific innovations from the Weizmann Institute and Shamir Medical Center.
Funding history · 1 round · $1.5M total
1 event/round · $1.5M Total Funding: $1.5M in Private Equity
Mar 2026
★ Mayo Clinic★ Israel Innovation Authority
Headcount over time
8 employees (2026-09) · 1 point
Offices
Tel Aviv, Israel · HQ / main office
Q&A
- What is Sub-Q Bionics' primary focus?
- Sub-Q Bionics is developing an implantable device for lymphedema patients that provides continuous fluid management as an alternative to daily compression therapy.
- When was Sub-Q Bionics founded?
- Sub-Q Bionics was founded in February 2025.
- What is the current employee count at Sub-Q Bionics?
- Sub-Q Bionics has 1-10 employees.
- What is the total amount of funding raised by Sub-Q Bionics to date?
- Sub-Q Bionics has raised a total of $1,500,000 USD.
- Who is the CEO of Sub-Q Bionics?
- Jordan Pollack is the CEO of Sub-Q Bionics.
- Who is the CTO of Sub-Q Bionics?
- David Knapp is the CTO of Sub-Q Bionics.
- What is Sub-Q Bionics' primary sector?
- Sub-Q Bionics' primary sector is Health Tech & Life Sciences.
- What is the current product stage of Sub-Q Bionics?
- Sub-Q Bionics' product is currently in the R&D stage.
Team · 17
Jordan Pollack
Founder · Chief Executive Officer
David Knapp
Chief Technology Officer
Gregg Pollack
Chief Financial Officer
Tom Sudow
Executive Chairman
Rachel Offenburg
VP Marketing & Investor Relations
Ben Friesem
R&D Advisor
Aaron Jaffee
Director
Sapir Dorkam
R&D Project Manager
Michael R.S.
R&D Advisor
Prof. Brian Berkowitz
Scientific Advisor
Dr. Lior Heller
Scientific Advisor
Dr. Dafna Politi Sofrin
Scientific Advisor - Physiotherapist
Dr. Daniel Kedar
Scientific Advisor
Dr. Yushi Suzuki
Scientific Advisor
Janie Finn
Patient Advocate
Dr. Antonios Gasparis
Scientific Advisor
Dr. Matthias Witt
Scientific Advisor
Sectors & technology
Primary sector
Medical Devices
Technologies
Target customers
Business model
B2B
Tags
women-healthmedical-devicesfemtechhealthcare
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | subqbionics.com/ |
|---|---|
| linkedin.com/company/107603751 |
Identifiers & details
| Legal name | SUB-Q BIONICS LTD |
|---|---|
| Founded | 2025 |
| Employees (exact) | 8 |
Radar intelligence
Web history (Wayback)
| Domain | subqbionics.com |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 517121844 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2025-02-17 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 2 — annual_report (1), other (1) |
| Registered address | הרצל 0 רחובות |
Recent registry events
| Date | Event |
|---|---|
| 2026-08-16 | דו~ח שנתי-שינוי בהוראות בתקנון |
| 2026-05-05 | עדכון כתובת ו/או מען דיגיטלי |